S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
U.S. Military Defense Fails Without Vanadium? (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
U.S. Military Defense Fails Without Vanadium? (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
U.S. Military Defense Fails Without Vanadium? (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
U.S. Military Defense Fails Without Vanadium? (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Evaxion Biotech A/S (EVAX) News Today

$0.62
-0.20 (-24.48%)
(As of 12/5/2023 ET)
Compare
Today's Range
$0.55
$0.77
50-Day Range
$0.62
$1.17
52-Week Range
$0.47
$2.44
Volume
763,628 shs
Average Volume
275,507 shs
Market Capitalization
$17.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
SourceHeadline
MarketBeat logoShort Interest in Evaxion Biotech A/S (NASDAQ:EVAX) Declines By 22.8%
americanbankingnews.com - December 3 at 1:42 AM
finance.yahoo.com logoEvaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
finance.yahoo.com - November 28 at 8:40 AM
finance.yahoo.com logoEvaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
finance.yahoo.com - November 15 at 8:55 AM
morningstar.com logoADRs End Lower; Evaxion Biotech A/S Declines 30%
morningstar.com - November 9 at 6:19 PM
finance.yahoo.com logoEvaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan Khattak
finance.yahoo.com - November 6 at 2:49 PM
morningstar.com logoADRs Hold Steady; Fresh2 Group Climbs 23%
morningstar.com - October 31 at 6:20 PM
finanznachrichten.de logoEvaxion Biotech: Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
finanznachrichten.de - October 31 at 1:20 PM
finance.yahoo.com logoEvaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
finance.yahoo.com - October 31 at 1:20 PM
finanznachrichten.de logoEvaxion Biotech: New and Exciting Clinical Data on Evaxion's AI-Immunology-Based Personalized Cancer Vaccines to be Presented
finanznachrichten.de - October 26 at 1:07 PM
tmcnet.com logoNew and Exciting Clinical Data on Evaxion's AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
tmcnet.com - October 26 at 1:07 PM
finance.yahoo.com logoNew and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
finance.yahoo.com - October 26 at 1:07 PM
finance.yahoo.com logoEvaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finance.yahoo.com - October 5 at 10:00 AM
finance.yahoo.com logoEvaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab
finance.yahoo.com - September 21 at 5:11 PM
finanznachrichten.de logoEvaxion Biotech: Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
finanznachrichten.de - September 20 at 3:29 PM
finance.yahoo.com logoEvaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
finance.yahoo.com - September 20 at 10:29 AM
finance.yahoo.com logoEvaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
finance.yahoo.com - September 18 at 10:08 AM
bloomberg.com logoNovo Buys Embark Biotech to Find New Avenues for Weight Loss
bloomberg.com - August 30 at 8:00 AM
finanznachrichten.de logoEvaxion Biotech: Evaxion announces Executive Management Changes to strengthen the AI-strategy
finanznachrichten.de - August 29 at 11:57 AM
finance.yahoo.com logoEvaxion announces Executive Management Changes to strengthen the AI-strategy
finance.yahoo.com - August 29 at 11:57 AM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Rising, Backed by Mostly Firmer Markets
msn.com - August 24 at 8:57 AM
finance.yahoo.com logoEvaxion Biotech A/S (NASDAQ:EVAX) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 23 at 5:48 PM
finance.yahoo.com logoQ2 2023 Evaxion Biotech A/S Earnings Call
finance.yahoo.com - August 23 at 3:22 AM
finanznachrichten.de logoEvaxion Biotech: Evaxion Announces Business Update and Second Quarter 2023 Financial Results
finanznachrichten.de - August 18 at 5:57 PM
finance.yahoo.com logoEvaxion Announces Business Update and Second Quarter 2023 Financial Results
finance.yahoo.com - August 18 at 5:57 PM
msn.com logoEvaxion Biotech: Personalized Cancer Vaccine Biotech With Q4 2023 Catalyst
msn.com - August 3 at 12:11 PM
msn.com logoEvaxion gets $20M financing from Negma
msn.com - August 1 at 9:43 PM
finance.yahoo.com logoEvaxion announces financing commitments totaling up to USD 20 million with Negma Group
finance.yahoo.com - August 1 at 11:30 AM
finance.yahoo.com logoEvaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
finance.yahoo.com - July 31 at 11:44 AM
seekingalpha.com logoIovance Biotherapeutics: More Than A One-Shot Wonder
seekingalpha.com - July 10 at 10:46 PM
axios.com logoThermo Fisher to buy Audax’s CorEvitas for $913M
axios.com - July 8 at 3:19 AM
foxnews.com logoCancer drug firms soar as positive clinical trial data ignites investor excitement
foxnews.com - June 8 at 11:49 AM
marketwatch.com logoADRs End Mostly Lower, BiondVax, Evaxion Biotech Trade Actively
marketwatch.com - June 5 at 10:01 PM
news.yahoo.com logoCancer drugmakers rise as industry meet fuels investor interest
news.yahoo.com - June 5 at 12:01 PM
marketwatch.com logoEvaxion Biotech Shares Rise 38% After Positive EVX-01 Phase 1 Trial Data
marketwatch.com - June 5 at 12:01 PM
finance.yahoo.com logoWhy Are Evaxion Biotech Shares Trading Higher Today
finance.yahoo.com - June 5 at 12:01 PM
finance.yahoo.com logoEvaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
finance.yahoo.com - June 3 at 9:03 PM
msn.com logoEuropean Equities Recover Some Losses in Thursday Trading
msn.com - June 1 at 1:16 PM
finance.yahoo.com logoAnalysts Expect Breakeven For Evaxion Biotech A/S (NASDAQ:EVAX) Before Long
finance.yahoo.com - June 1 at 8:15 AM
finance.yahoo.com logoEvaxion Announces Business Update and First Quarter 2023 Financial Results
finance.yahoo.com - May 31 at 11:04 AM
finance.yahoo.com logoEvaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01
finance.yahoo.com - May 25 at 7:09 PM
thestreet.com logoElan's Martin Named Worst Biotech CEO of '08
thestreet.com - May 21 at 8:29 PM
finance.yahoo.com logoEvaxion to host R&D Day on May 25, 2023
finance.yahoo.com - May 16 at 8:49 AM
finance.yahoo.com logoFourth quarter and full year 2022 financial results and business update
finance.yahoo.com - April 27 at 9:51 AM
msn.com logoEvaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
msn.com - April 18 at 9:21 PM
finance.yahoo.com logoEvaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints
finance.yahoo.com - April 18 at 9:57 AM
finanznachrichten.de logoEvaxion Biotech: Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform
finanznachrichten.de - April 14 at 6:53 PM
finance.yahoo.com logoEvaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform
finance.yahoo.com - April 13 at 12:51 PM
markets.businessinsider.com logoLake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX)
markets.businessinsider.com - March 31 at 12:47 PM
finanznachrichten.de logoEvaxion Biotech: Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients
finanznachrichten.de - March 28 at 10:31 AM
finance.yahoo.com logoEvaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients
finance.yahoo.com - March 28 at 10:31 AM
Get Evaxion Biotech A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.



EVAX Media Mentions By Week

EVAX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVAX
News Sentiment

0.93

0.39

Average
Medical
News Sentiment

EVAX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVAX Articles
This Week

2

1

EVAX Articles
Average Week

Get Evaxion Biotech A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:EVAX) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -